Subtype

Bladder Neoplasm

CI-CAN-00001978Explore in graph →

Non-malignant390 active trials10 approved drugs25 evidence items

NCIt: C2901
MeSH: D001749

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (139)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 139 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Editor's corner: Heavy metal exposure and the epigenetic landscape of urothelial bladder cancer.
Marianna Kruithof-deJulio · Gene · Dec 5, 2026 · PMID 42692175 · candidate dictionary pubmed
Cost-effectiveness of perioperative pembrolizumab plus enfortumab vedotin for cisplatin-ineligible or cisplatin-declining patients with muscle-invasive bladder cancer in the United States.
Daniel Hill-McManus, Yizhen Lai, Arielle G Bensimon et al. · J Med Econ · Dec 1, 2026 · PMID 42610318 · candidate dictionary pubmed
[Expression of Concern] RIP kinase‑mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin‑treated bladder cancer cells.
Yoon Hee Chung, Daejin Kim · Oncol Rep · Nov 1, 2026 · PMID 42757458 · candidate dictionary pubmed
Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer - a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100.
Xin Li, Yapeng Xing · Eur Urol Open Sci · Nov 1, 2026 · PMID 42787789 · candidate dictionary pubmed
Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle-Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report.
Yosuke Nakanishi, Yohei Kawashima, Masanao Shinohara et al. · IJU Case Rep · Nov 1, 2026 · PMID 42800938 · candidate dictionary pubmed
[Corrigendum] Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell‑like side population cells.
Dingjun Zhu, Xuesi Wan, Hai Huang et al. · Oncol Rep · Oct 1, 2026 · PMID 42596854 · candidate dictionary

pubmed

PD09-07 Durvalumab in Combination with Bacillus Calmette-Guérin for Bacillus Calmette-Guérin-Naïve, High-Risk Non-Muscle-Invasive Bladder Cancer: Primary Results from a US-Based, Phase IIIB, Open-Label, Single-Arm, Multicenter Study (PATAPSCO): Erratum.

Gautam Jayram, Neal D Shore, Mark Tyson et al. · J Urol · Oct 1, 2026 · PMID 42713894 · candidate dictionary pubmed

Durvalumab in Combination with Bacillus Calmette-Guérin Induction and Maintenance Therapy for Bacillus Calmette-Guérin-Naïve, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum.

Neal D Shore, Hiroyuki Nishiyama, Joan Palou Redorta et al. · J Urol · Oct 1, 2026 · PMID 42713893 · candidate dictionary pubmed

Associations between a mixture of trace elements and bladder cancer occurrence: A study of possible reverse causation.

Maria E Kamenetsky, Stella Koutros, Maya Spaur et al. · Environ Epidemiol · Oct 1, 2026 · PMID 42725121 · candidate dictionary pubmed

An engineered bacteria-chitosan hybrid robot for lactate depletion and synergistic STING activation to potentiate bladder cancer immunotherapy.

Baodan Zhang, Jie Zhu, Zhenyu Hong et al. · Mater Today Bio · Oct 1, 2026 · PMID 42730040 · candidate dictionary pubmed

Longitudinal Economic Burden for Non-Muscle-Invasive Bladder Cancer by EAU Progression Risk Groups Using the Prospective Multicenter COBLAnCE Cohort Linked to the French National Healthcare System Database.

Aldéric M Fraslin, Simone Benhamou, Thierry Lebret et al. · Eur Urol Open Sci · Oct 1, 2026 · PMID 42740896 · candidate dictionary pubmed

A blood-urine regulatory axis: Tumor-derived factors reprogram urine-derived stem cells via CXCL2/CXCR2/ERK signaling to drive bladder cancer stemness.

Dongkai Sun, Chunhua Han, Dan Li et al. · Cancer Lett · Sep 28, 2026 · PMID 42285214 · candidate dictionary pubmed

Global trends and hotspots in bladder cancer: A bibliometric analysis (2016-2025).

Rakesh Heer, Mehrdad Farrokhi · Urologia · Sep 28, 2026 · PMID 42803329 · candidate dictionary pubmed

Correction to "Gut Parabacteroides distasonis-Derived Indole-3-Acetic Acid Promotes Phospholipid Remodeling and Enhances Ferroptosis Sensitivity via the AhR‒FASN Axis in Bladder Cancer".

· Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801597 · candidate dictionary pubmed

Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.

Linhui Wang, Xiaomeng Liu, Tao Zhu et al. · Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801591 · candidate dictionary pubmed

A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer.

C Guerrero Quiles, H Abumanhal-Masarweh, J G Abalos et al. · Br J Cancer · Sep 26, 2026 · PMID 42800813 · candidate dictionary pubmed

Reply to Roberto M. Scarpa's Letter to the Editor re: Paolo Gontero, Richard Perry, Daisy Bridge, et al. Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus. Eur Urol Oncol 2026;9(3):652-9.

Paolo Gontero, Marek Babjuk · Eur Urol Oncol · Sep 26, 2026 · PMID 42800742 · candidate dictionary pubmed

Re: Matthew D. Galsky and Andrea Necchi. Cystectomy Can Be Spared in Selected Patients with Muscle-invasive Bladder Cancer and Complete Response Following Neoadjuvant Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.07.014.

Pietro Scilipoti, Francesco Montorsi · Eur Urol · Sep 26, 2026 · PMID 42800733 · candidate dictionary pubmed

Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer.

Lea Mantz, Alex Zhu, Nathaniel D Mercaldo et al. · Urol Oncol · Sep 26, 2026 · PMID 42800379 · candidate dictionary pubmed

Serum Galectin-3 as a complementary biomarker in non-muscle-invasive bladder cancer.

Recep Eryılmaz, Muhammed Fatih Keleş, Rahmi Aslan et al. · Urol Oncol · Sep 26, 2026 · PMID 42800378 · candidate dictionary pubmed

Concurrent extension of bladder cancer to the intramural ureter and prostatic urethra increases the risk of urethral cancer in patients undergoing radical cystectomy.

Yutaro Hayashi, Ryo Yamashita, Yuma Sakura et al. · Int Urol Nephrol · Sep 26, 2026 · PMID 42799953 · candidate dictionary pubmed

Introducing "HEDGE": sequential intravesical gemcitabine-based thermochemotherapy (HIVEC) plus docetaxel as a potential novel bladder-sparing strategy for BCG-unresponsive non-muscle-invasive bladder cancer.

Lampros Mitrakas, Athanasios Zisopoulos, Konstantinos Dimitropoulos et al. · Arch Ital Urol Androl · Sep 25, 2026 · PMID 42714388 · candidate dictionary pubmed

Phenanthrene Derivatives from Arundina graminifolia Inhibit the Migration and Proliferation of Human Bladder Cancer Cells.

Xingyu Zhang, Songlin Yu, Shiquan Liu et al. · Anticancer Agents Med Chem · Sep 25, 2026 · PMID 42786873 · candidate dictionary pubmed

Re: Valentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al. Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol 2026;90:7-12.

Ahmed M Elalfy · Eur Urol · Sep 25, 2026 · PMID 42791106 · candidate dictionary pubmed

Simpler risk stratification and new options for recurrent low-grade disease: 2026 update to the AUA/SUO non-muscle invasive bladder cancer guideline.

David J Nusbaum, Scott M Gilbert, Roger Li · J Urol · Sep 24, 2026 · PMID 42784640 · candidate dictionary pubmed